# Sublingual vs IV Atropine Bioavailability Study

> **NCT04290039** · PHASE1 · COMPLETED · sponsor: **Biomedical Advanced Research and Development Authority** · enrollment: 15 (actual)

## Conditions studied

- Toxic Effect of Organophosphate and Carbamate Insecticides

## Interventions

- **DRUG:** Atropine Sulfate Ophthalmic Solution
- **DRUG:** Atropine Sulphate Injection

## Key facts

- **NCT ID:** NCT04290039
- **Lead sponsor:** Biomedical Advanced Research and Development Authority
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-04
- **Primary completion:** 2020-02-02
- **Final completion:** 2020-02-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04290039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04290039, "Sublingual vs IV Atropine Bioavailability Study". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT04290039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*